Pakistani doctors on Saturday claimed a successful clinical trial of passive immuinization after a coronavirus patient recovered through plasma therapy.<\/p>\n
“Alhamdolillah, (by the grace ofg God), the first coronavirus patient treated through passive immuinization has recovered, and discharged from the hospital,” Dr Tahir Shamsi , head of the National Institute of Blood Diseases, told Anadolu Agency.<\/p>\n
He, however, refused to reveal the details of the patient, and the hospital where he was treated.<\/p>\n
Currently, he added, several COVID-19 patients were undergoing the plasma therapy as the authorities had set a target of 350 patients to undergo the clinical trial.<\/p>\n
Eight approved clinical trial facilities for convalescent plasma across Pakistan, have already begun the process of collecting the plasma of patients recovered from the coronavirus.<\/p>\n
“Let me make it very clear that it’s a successful clinical trial only. We cannot declare it an approved treatment for the novel virus at this stage,” said Shamsi , who heads the team of hematologists that has been assigned for the clinical trials.<\/p>\n
“We still have to wait to say something definitive in this regard after more and more successful clinical trials,” he maintained.<\/p>\n
Passive immunization is not a new medical treatment and has been done for the last 125 years.<\/p>\n
According to Shamsi, the therapy was used to cure patients of diseases like SARS, Ebola and influenza in the recent past.<\/p>\n
At present, he went on to say, the method was being used at 1,500 hospitals in some 80 countries to cure the coronavirus patients.<\/p>\n
Pakistan is the worst-hit country in the region from the virus, with the total number of cases reaching 28,736 with 636 deaths.<\/p>\n","protected":false},"excerpt":{"rendered":"
Pakistani doctors on Saturday claimed a successful clinical trial of passive immuinization after a coronavirus patient recovered through plasma therapy. “Alhamdolillah, (by the grace ofg God), the first coronavirus patient treated through passive immuinization has recovered, and discharged from the hospital,” Dr Tahir Shamsi , head of the National Institute of Blood Diseases, told Anadolu […]<\/p>\n","protected":false},"author":5,"featured_media":13992,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,31,32],"tags":[],"class_list":["post-14453","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","category-news","category-pakistan"],"_links":{"self":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/14453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/comments?post=14453"}],"version-history":[{"count":1,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/14453\/revisions"}],"predecessor-version":[{"id":14454,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/14453\/revisions\/14454"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/media\/13992"}],"wp:attachment":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/media?parent=14453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/categories?post=14453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/tags?post=14453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}